UNII 9XZ8H6N6OH
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
Unique Ingredient Identifier 9XZ8H6N6OH is listed as a unspecified ingredient
| Unii | 9XZ8H6N6OH |
| Preferred Substance Name | HYDROXYPROPYL CELLULOSE, UNSPECIFIED |
| Rn | 9004-64-2 |
| Ncit | C174593 |
| Rxcui | 1804020 |
| Inn Id | 7725 |
| Unii Type | UNSPECIFIED INGREDIENT
|
| RN | 9004-64-2 |
| RXCUI | 1804020 |
| INN ID | 7725 |
Alternate Names
- CELLULOSE HYDROXYPROPYL ETHER
- CELLULOSE, 2-HYDROXYPROPYL ETHER
- E-463
- HYDROXY PROPYL CELLULOSE
- HYDROXY PROPYL CELLULOSE NF
- HYDROXYPROPYL CELLULOSE
- HYDROXYPROPYL CELLULOSE [FCC]
- HYDROXYPROPYL CELLULOSE [II]
- HYDROXYPROPYL CELLULOSE [MI]
- HYDROXYPROPYL CELLULOSE [ORANGE BOOK]
- HYDROXYPROPYL CELLULOSE [VANDF]
- HYDROXYPROPYL CELLULOSE NF
- HYDROXYPROPYL CELLULOSE, UNSPECIFIED
- HYDROXYPROPYLCELLULOSE
- HYDROXYPROPYLCELLULOSE [EP]
- HYDROXYPROPYLCELLULOSE [INCI]
- HYDROXYPROPYLCELLULOSE [JAN]
- HYPROLOSE
- HYPROLOSE [INN]
- HYPROLOSE [WHO-DD]
- INS NO.463
- INS-463
- LACRISERT
- MODIFIED CELLULOSE
Dosage Forms
UNII 9XZ8H6N6OH HYDROXYPROPYL CELLULOSE, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|
| ORAL | CAPSULE | 3 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 94.29 MG |
| ORAL | TABLET | 95 MG |
| ORAL | TABLET, EXTENDED RELEASE | 140 MG |
© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.